Atlas Trials

Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal Cancer

Clinical trial NCT04134897 · UNKNOWN

Trial details

NCT number
NCT04134897
Sponsor
Blokhin's Russian Cancer Research Center
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Rectal Neoplasms MalignantRectum CarcinomaRectal Cancer
Start date
2019-10-14
Primary completion
2024-10-01
Enrollment
316

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.